Navigation Links
Eric Tornoe Joins Exagen Diagnostics as President and COO
Date:8/10/2011

ALBUQUERQUE, N.M., Aug. 10, 2011 /PRNewswire/ -- Exagen Diagnostics, Inc., a specialty focused molecular diagnostics laboratory that discovers, develops and markets proprietary tests for rheumatologists and gastroenterologists, announced today the appointment of Eric Tornoe as President and Chief Operating Officer.

Tornoe has more than 20 years of healthcare industry experience in sales, sales management and marketing, making him a key hire as Exagen broadens its test menu and moves to the next level of growth.  Prior to Exagen, he worked for Pfizer Inc., Wyeth and Bristol-Myers Squibb Co., quickly advancing his career in a number of senior management positions that dramatically expanded revenues.  He has a reputation for building effective business units, creating partnerships and developing collaborative relationships.  Tornoe has a depth of operational expertise in the rheumatology market and a track record of successfully developing and implementing strategic plans.

"This is an exciting time at Exagen as our product line expands and sales grow," said Scott Glenn, board chairman and CEO.  "Eric has a great track record in leading and directing teams to exceed corporate business and revenue objectives.   He will play an instrumental role in the ongoing success of the company and its continued focus on personalized medicine."

About Exagen

Exagen is the emerging leader in laboratory-discovered and developed genomic tests specifically designed to provide objective information to physicians and patients for more accurate, efficient diagnosis and better disease management. Using Coperna, the company's proprietary, algorithm-driven computational tool and search engine that runs on high-performance computational clusters, it combines the ability to process massive amounts of data contained in genomic datasets with intelligent, rapid search methods. Coperna's targeted and precise discovery model has no conventional equivalent in the molecular diagnostics industry as it can identify relevant marker sets with superior sensitivity and specificity relative to markers identified via traditional analytical methods. For more information, please visit www.exagen.com.


'/>"/>
SOURCE Exagen Diagnostics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Kelly Price Joins Los Angeles County Affiliate of Susan G. Komen for the Cure in the Fight Against Breast Cancer
2. Andrea Drucker Joins Insmed as General Counsel
3. Coloredge New York - Los Angeles Joins DuPont™ Tyvek® Graphics Authorized Printer Network
4. Jeff Sherman Joins Block Engineering as Vice President of Worldwide Sales
5. Laszlo Radvanyi, Ph.D. Joins Genesis Biopharma Scientific and Medical Advisory Board
6. Dr. Joel Posener Joins PharmaNet as Executive Medical Director, Neuroscience
7. Eduard Alberts, Ph.D. Joins Sanford Rose Associates - San Francisco
8. Amicus Therapeutics Joins Russell 3000® Index
9. Dr. H. Daniel Perez Joins Celtaxsys Board of Directors
10. Governor Gray Davis Joins Genesis Biopharma as Chairman of Corporate Advisory Board
11. Matthias Spaenle, MD, Joins Oppenheimers Investment Banking Group as Managing Director - Healthcare
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... October 11, 2017 , ... At its ... announced Dr. Suneel I. Sheikh, the co-founder, CEO and chief research scientist of ... been selected for membership in ARCS Alumni Hall of Fame . ASTER ...
(Date:10/11/2017)... ... October 11, 2017 , ... ComplianceOnline’s Medical Device Summit ... 7th and 8th June 2018 in San Francisco, CA. The Summit brings together current ... several distinguished CEOs, board directors and government officials from around the world to address ...
(Date:10/11/2017)... LAGUNA HILLS, Calif. , Oct. 11, 2017  SkylineDx ... London (ICR) and University of Leeds ... to risk-stratify patients with multiple myeloma (MM), in a multi-centric ... The University of Leeds is the ... UK, and ICR will perform the testing services to include ...
(Date:10/11/2017)... ... October 11, 2017 , ... ... has granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer and ... of osteosarcoma. SBT-100 is able to cross the cell membrane and bind intracellular ...
Breaking Biology Technology:
(Date:8/15/2017)... , Aug. 15 2017   ivWatch LLC , a ... intravenous (IV) therapy, today announced receipt of its ISO 13485 Certification, ... by the International Organization for Standardization (ISO®). ... ivWatch Model 400 Continuous Monitoring device for the early ... "This is an ...
(Date:5/23/2017)... May 23, 2017  Hunova, the first robotic gym for the rehabilitation ... officially launched in Genoa, Italy . The first 30 ... and the USA . The technology was developed and ... by the IIT spin-off Movendo Technology thanks to a 10 million euro ... Release, please click: ...
(Date:4/19/2017)... April 19, 2017 The global ... landscape is marked by the presence of several large ... held by five major players - 3M Cogent, NEC ... accounted for nearly 61% of the global military biometric ... in the global military biometrics market boast global presence, ...
Breaking Biology News(10 mins):